Home
About
Overview
Sharing Data
ORCID
Help
History (1)
SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.
SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 May; 165(4):504-9.
View in:
PubMed
subject areas
Adenine Nucleotides
Adult
Aged
Antibodies, Monoclonal, Humanized
Antigens, Neoplasm
Antineoplastic Combined Chemotherapy Protocols
Arabinonucleosides
Chemical and Drug Induced Liver Injury
Cytarabine
Febrile Neutropenia
Female
Heart Arrest
Hematologic Diseases
Humans
Male
Middle Aged
Neoplasm, Residual
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Remission Induction
Risk
Salvage Therapy
Sialic Acid Binding Ig-like Lectin 2
Treatment Outcome
Young Adult
authors with profiles
Michael A. Becker